Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Turning off the inflammatory, but not the metabolic, flames

This article has been updated

Metabolically driven, chronic, low-grade inflammation has a crucial role in the pathogenesis of obesity and type 2 diabetes, and multiple stress-signaling cascades link insulin resistance and the immune response. An approved immunomodulatory drug is now shown to inhibit the kinases IKKε and TBK1, suppress inflammation and improve metabolic homeostasis in mouse models of obesity (pages 313–321).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Figure 1: Signaling pathways involved in classical inflammation and metaflammation.

Marina Corral

Change history

  • 22 March 2013

     In the version of this article initially published, TBK1 was incorrectly referred to in a number of instances as TKB1. The error has been corrected in the HTML and PDF versions of the article.


  1. Gregor, M.F. & Hotamisligil, G.S. Annu. Rev. Immunol. 29, 415–445 (2011).

    Article  CAS  Google Scholar 

  2. Olefsky, J.M. & Glass, C.K. Annu. Rev. Physiol. 72, 219–246 (2010).

    Article  CAS  Google Scholar 

  3. Odegaard, J.I. & Chawla, A. Science 339, 172–177 (2013).

    Article  CAS  Google Scholar 

  4. Johnson, A.R., Milner, J.J. & Makowski, L. Immunol. Rev. 249, 218–238 (2012).

    Article  CAS  Google Scholar 

  5. Hirosumi, J. et al. Nature 420, 333–336 (2002).

    Article  CAS  Google Scholar 

  6. Yuan, M. et al. Science 293, 1673–1677 (2001).

    Article  CAS  Google Scholar 

  7. Arkan, M.C. et al. Nat. Med. 11, 191–198 (2005).

    Article  CAS  Google Scholar 

  8. Nakamura, T. et al. Cell 140, 338–348 (2010).

    Article  CAS  Google Scholar 

  9. Carvalho-Filho, M.A. et al. Endocrinology 153, 5261–5274 (2012).

    Article  CAS  Google Scholar 

  10. Reilly, S.M. et al. Nat. Med. 19, 313–321 (2013).

    Article  CAS  Google Scholar 

  11. Baker, R.G., Hayden, M.S. & Ghosh, S.N.F. Cell Metab. 13, 11–22 (2011).

    Article  CAS  Google Scholar 

  12. Chiang, S.-H. et al. Cell 138, 961–975 (2009).

    Article  CAS  Google Scholar 

  13. Scheja, L., Heese, B. & Seedorf, K. Biochem. Biophys. Res. Commun. 407, 288–294 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Gökhan S. Hotamisligil.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Calay, E., Hotamisligil, G. Turning off the inflammatory, but not the metabolic, flames. Nat Med 19, 265–267 (2013).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing